• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纯导管原位癌(DCIS)保乳治疗中,肿瘤大小的放射学低估作为切缘阳性率的相关危险因素。

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).

作者信息

Schultek Gesche, Gerber Bernd, Reimer Toralf, Stubert Johannes, Hartmann Steffi, Martin Annett, Stachs Angrit

机构信息

Department of Obstetrics and Gynecology, University of Rostock, 18059 Rostock, Germany.

出版信息

Cancers (Basel). 2022 May 11;14(10):2367. doi: 10.3390/cancers14102367.

DOI:10.3390/cancers14102367
PMID:35625972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9139437/
Abstract

Background: Radiological underestimation of the actual tumor size is a relevant problem in reaching negative margins in ductal carcinoma in situ (DCIS) associated with microcalcifications in breast-conserving therapy (BCT). The aim of this study is to evaluate whether the radiological underestimation of tumor size has an influence on the histopathological margin status. Methods: Patients who underwent BCT with preoperatively diagnosed pure DCIS were included (pooled analysis of two trials). Multiple factors were analysed regarding radiological underestimation ≥10 mm. Radiological underestimation was defined as mammographic minus histological tumor size in mm. Results: Positive margins occurred in 75 of 189 patients. Radiological underestimation ≥10 mm was an independent influencing factor (OR 5.80; 95%CI 2.55−13.17; p < 0.001). A radiological underestimation was seen in 70 patients. The following parameters were statistically significant associated with underestimation: pleomorphic microcalcifications (OR 3.77; 95%CI 1.27−11.18), clustered distribution patterns (OR 4.26; 95%CI 2.25−8.07), and mammographic tumor sizes ≤20 mm (OR 7.47; 95%CI 3.49−15.99). Only a mammographic tumor size ≤20 mm was an independent risk factor (OR 6.49; 95%CI 2.30−18.26; p < 0.001). Grading, estrogen receptor status, and comedo necrosis did not influence the size estimation. Conclusion: Radiological underestimation is an independent risk factor for positive margins in BCT of DCIS associated with microcalcifications predominantly occurring in mammographic small tumors.

摘要

背景

在保乳治疗(BCT)中,对于伴有微钙化的导管原位癌(DCIS),放射学对实际肿瘤大小的低估是实现切缘阴性的一个相关问题。本研究的目的是评估肿瘤大小的放射学低估是否对组织病理学切缘状态有影响。方法:纳入术前诊断为纯DCIS并接受BCT的患者(两项试验的汇总分析)。分析了与放射学低估≥10 mm相关的多个因素。放射学低估定义为乳腺X线摄影测量的肿瘤大小减去组织学测量的肿瘤大小(单位为mm)。结果:189例患者中有75例切缘阳性。放射学低估≥10 mm是一个独立影响因素(比值比5.80;95%置信区间2.55 - 13.17;p < 0.001)。70例患者存在放射学低估。以下参数与低估在统计学上显著相关:多形性微钙化(比值比3.77;95%置信区间1.27 - 11.18)、簇状分布模式(比值比4.26;95%置信区间2.25 - 8.07)以及乳腺X线摄影测量的肿瘤大小≤20 mm(比值比7.47;95%置信区间3.49 - 15.99)。只有乳腺X线摄影测量的肿瘤大小≤20 mm是一个独立危险因素(比值比6.49;95%置信区间2.30 - 18.26;p < 0.001)。分级、雌激素受体状态和粉刺样坏死不影响大小估计。结论:放射学低估是BCT治疗伴有微钙化的DCIS时切缘阳性的独立危险因素,微钙化主要出现在乳腺X线摄影测量的小肿瘤中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c7/9139437/9430ada8e499/cancers-14-02367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c7/9139437/d3af2fd83245/cancers-14-02367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c7/9139437/9430ada8e499/cancers-14-02367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c7/9139437/d3af2fd83245/cancers-14-02367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c7/9139437/9430ada8e499/cancers-14-02367-g002.jpg

相似文献

1
Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).在纯导管原位癌(DCIS)保乳治疗中,肿瘤大小的放射学低估作为切缘阳性率的相关危险因素。
Cancers (Basel). 2022 May 11;14(10):2367. doi: 10.3390/cancers14102367.
2
The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.标本放射摄影在导管原位癌保乳治疗中的作用。
Breast. 2016 Apr;26:73-9. doi: 10.1016/j.breast.2015.12.014. Epub 2016 Feb 1.
3
Ductal Carcinoma In Situ Underestimation of Microcalcifications Only by Stereotactic Vacuum-Assisted Breast Biopsy: A New Predictor of Specimens without Microcalcifications.仅通过立体定位真空辅助乳腺活检对导管原位癌微钙化的低估:无微钙化标本的新预测指标
J Clin Med. 2020 Sep 17;9(9):2999. doi: 10.3390/jcm9092999.
4
Factors affecting successful breast conservation for ductal carcinoma in situ.影响导管原位癌保乳成功的因素。
Ann Surg Oncol. 2007 May;14(5):1618-28. doi: 10.1245/s10434-006-9246-y. Epub 2007 Feb 14.
5
Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.乳腺钼靶检查中微钙化的范围和雌激素受体表达影响术前原位乳腺癌大小的估计。
Breast Cancer. 2017 May;24(3):466-472. doi: 10.1007/s12282-016-0729-9. Epub 2016 Sep 17.
6
Predictors of surgical margin status in breast-conserving surgery within a breast screening program.乳腺筛查项目中保乳手术切缘状态的预测因素
Ann Surg Oncol. 2008 Sep;15(9):2542-9. doi: 10.1245/s10434-008-0054-4. Epub 2008 Jul 10.
7
Contrast-Enhanced Mammographic Features of In Situ and Invasive Ductal Carcinoma Manifesting Microcalcifications Only: Help to Predict Underestimation?仅表现为微钙化的原位及浸润性导管癌的对比增强乳腺X线特征:有助于预测低估情况吗?
Cancers (Basel). 2021 Aug 30;13(17):4371. doi: 10.3390/cancers13174371.
8
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
9
Screen-detected ductal carcinoma in situ found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications without mass: radiological-histological correlation.在无肿块的可疑微钙化灶的立体定向真空辅助活检中发现的筛查原位导管癌:放射学与组织学相关性
Radiol Oncol. 2016 Apr 23;50(2):145-52. doi: 10.1515/raon-2016-0020. eCollection 2016 Jun 1.
10
Is There Any Association Between Mammographic Features of Microcalcifications and Breast Cancer Subtypes in Ductal Carcinoma In Situ?微钙化的乳腺 X 线特征与导管原位癌中乳腺癌亚型之间是否存在关联?
Acad Radiol. 2021 Jul;28(7):963-968. doi: 10.1016/j.acra.2020.05.032. Epub 2020 Jun 30.

引用本文的文献

1
Artificial intelligence-based tumor size measurement on mammography: agreement with pathology and comparison with human readers' assessments across multiple imaging modalities.基于人工智能的乳腺钼靶摄影肿瘤大小测量:与病理结果的一致性以及与人类阅片者在多种成像模态下评估结果的比较。
Radiol Med. 2025 Jun 20. doi: 10.1007/s11547-025-02033-8.
2
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patients.人工智能驱动的可视化软件平台在乳腺癌患者精准手术中的性能
NPJ Breast Cancer. 2024 Nov 14;10(1):98. doi: 10.1038/s41523-024-00696-6.
3
Local recurrence and residual tumor rates following cryoablation for small early-stage breast cancers: systemic review and meta-analysis.

本文引用的文献

1
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).术前乳腺磁共振成像在导管原位癌患者中的应用: 欧洲委员会乳腺癌倡议(ECIBC)的系统评价。
Eur Radiol. 2021 Aug;31(8):5880-5893. doi: 10.1007/s00330-021-07873-2. Epub 2021 May 30.
2
Intraoperative Evaluation of Resection Margins in Breast-Conserving Surgery for and Invasive Breast Carcinoma.保乳手术治疗导管原位癌和浸润性乳腺癌时切缘的术中评估
Breast Cancer (Auckl). 2021 Mar 30;15:1178223421993459. doi: 10.1177/1178223421993459. eCollection 2021.
3
早期小乳腺癌冷冻消融术后的局部复发率和残留肿瘤率:系统评价与荟萃分析
Breast Cancer. 2025 Jan;32(1):69-78. doi: 10.1007/s12282-024-01643-w. Epub 2024 Oct 19.
4
Surgical De-Escalation for Re-Excision in Patients with a Margin Less Than 2 mm and a Diagnosis of DCIS.切缘小于2mm且诊断为导管原位癌患者再次切除的手术降级治疗
Cancers (Basel). 2024 Feb 10;16(4):743. doi: 10.3390/cancers16040743.
Measurements using mammography and ultrasonography underestimate the size of high-volume ductal carcinoma in situ.
使用乳腺 X 线摄影术和超声检查会低估大体积导管原位癌的大小。
Am J Surg. 2021 Jun;221(6):1167-1171. doi: 10.1016/j.amjsurg.2021.03.043. Epub 2021 Mar 24.
4
Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.使用 C2Am 对乳腺高危导管原位癌进行多模态成像:一种靶向细胞死亡成像剂。
Breast Cancer Res. 2021 Feb 17;23(1):25. doi: 10.1186/s13058-021-01404-z.
5
Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?治疗(低风险)导管原位癌患者:我们能从真实世界癌症登记数据中学到什么?
Breast Cancer Res Treat. 2021 May;187(1):187-196. doi: 10.1007/s10549-020-06042-1. Epub 2021 Jan 3.
6
Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ.纯导管原位癌患者中切缘刮除对切缘状态的影响。
J Am Coll Surg. 2021 Apr;232(4):373-378. doi: 10.1016/j.jamcollsurg.2020.11.019. Epub 2020 Dec 18.
7
Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.保乳手术治疗导管原位癌的再次切除术预测因素。
Ann Surg Oncol. 2021 Mar;28(3):1390-1397. doi: 10.1245/s10434-020-09101-5. Epub 2020 Sep 10.
8
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.在一项大规模国际评分者间可靠性研究中,组织病理学导管原位癌特征的预后价值
Breast Cancer Res Treat. 2020 Oct;183(3):759-770. doi: 10.1007/s10549-020-05816-x. Epub 2020 Jul 30.
9
Preoperative MRI Improves Surgical Planning and Outcomes for Ductal Carcinoma in Situ.术前磁共振成像可改善导管原位癌的手术规划及治疗效果。
Radiology. 2020 May;295(2):304-306. doi: 10.1148/radiol.2020200076. Epub 2020 Mar 17.
10
Surgical Outcomes for Ductal Carcinoma in Situ: Impact of Preoperative MRI.导管原位癌的手术治疗效果:术前 MRI 的影响。
Radiology. 2020 May;295(2):296-303. doi: 10.1148/radiol.2020191535. Epub 2020 Mar 17.